Low-FODMAP Diet for Irritable Bowel Syndrome: What We Know and What We Have Yet to Learn
| Autor: | Shanti Eswaran, William D. Chey, Jerry Liu, Emily Haller |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Gi symptoms
medicine.medical_specialty Oligosaccharides Lactose Fructose Disaccharides Gastroenterology General Biochemistry Genetics and Molecular Biology Permeability Irritable Bowel Syndrome 03 medical and health sciences Diet Carbohydrate-Restricted 0302 clinical medicine Internal medicine Medicine Humans Intestinal Mucosa Irritable bowel syndrome chemistry.chemical_classification business.industry Monosaccharides General Medicine medicine.disease Fructans Gastrointestinal Microbiome Glucose Treatment Outcome chemistry 030220 oncology & carcinogenesis Low fodmap diet Fermentation 030211 gastroenterology & hepatology business FODMAP Gastrointestinal Motility |
| Zdroj: | Annual review of medicine. 71 |
| ISSN: | 1545-326X |
| Popis: | Irritable bowel syndrome (IBS) is the most prevalent of gastrointestinal (GI) conditions, affecting millions of people worldwide. Given that most IBS patients associate their GI symptoms with eating food, specific dietary manipulation has become an attractive treatment strategy. A diet low in FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides, and polyols) has generated the greatest level of scientific and clinical interest. Overall, 52–86% of patients report significant improvement of their IBS symptoms with elimination of dietary FODMAPs. Patients who experience symptom improvement with FODMAP elimination should undergo a structured reintroduction of foods containing individual FODMAPs to determine sensitivities and allow for personalization of the diet plan. This review discusses the literature surrounding the administration of the low-FODMAP diet and its efficacy in the treatment of IBS. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|